Department of Psychological Medicine, King's College London, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), London, UK
South London and Maudsley (SLaM) NHS Trust, London, UK.
BMJ Open Diabetes Res Care. 2021 Sep;9(1). doi: 10.1136/bmjdrc-2021-002118.
Using data from a a primary care pay-for-performance scheme targeting quality indicators, the objective of this study was to assess if people living with type 2 diabetes mellitus (T2DM) and severe mental illnesses (SMI) experienced poorer glycemic management compared with people living with T2DM alone, and if observed differences varied by race/ethnicity, deprivation, gender, or exclusion from the scheme.
Primary care data from a cohort of 56 770 people with T2DM, including 2272 people with T2DM and SMI, from London (UK), diagnosed between January 17, 2008 and January 16, 2018, were used. Adjusted mean glycated hemoglobin (HbA1c) and HbA1c differences were assessed using multilevel regression models.
Compared with people with T2DM only, people with T2DM/SMI were more likely to be of an ethnic minority background, excluded from the pay-for-performance scheme and residing in more deprived areas. Across the sample, mean HbA1c was lower in those with T2DM and SMI (mean HbA1c: 58 mmol/mol; 95% CI 57 to 59), compared with people with T2DM only (mean HbA1c: 59 mmol/mol; 95% CI 59 to 60). However, HbA1c levels were greater in Bangladeshi, Indian, Pakistani, and Chinese people compared with the White British reference in the T2DM/SMI group. People with T2DM/SMI who had been excluded from the pay-for-performance scheme, had HbA1c levels which were +7 mmol/mol (95% CI 2 to 11) greater than those with T2DM/SMI not excluded. Irrespective of SMI status, increasing deprivation and male gender were associated with increased HbA1c levels.
Despite a pay-for-performance scheme to improve quality standards, inequalities in glycemic management in people with T2DM and SMI persist in those excluded from the scheme and by gender, ethnicity, and area-level deprivation.
本研究利用针对质量指标的初级保健按绩效付费计划的数据,评估患有 2 型糖尿病(T2DM)和严重精神疾病(SMI)的人与仅患有 T2DM 的人相比,血糖管理是否较差,以及观察到的差异是否因种族/民族、贫困程度、性别或被排除在计划之外而有所不同。
使用来自伦敦(英国)的 56770 名 T2DM 患者的队列中的初级保健数据,包括 2008 年 1 月 17 日至 2018 年 1 月 16 日期间诊断出的 2272 名 T2DM 和 SMI 患者。使用多层次回归模型评估调整后的平均糖化血红蛋白(HbA1c)和 HbA1c 差异。
与仅患有 T2DM 的患者相比,患有 T2DM/SMI 的患者更有可能属于少数民族背景,被排除在按绩效付费计划之外,并居住在更贫困的地区。在整个样本中,患有 T2DM 和 SMI 的患者的平均 HbA1c 较低(平均 HbA1c:58mmol/mol;95%CI 57 至 59),而仅患有 T2DM 的患者的平均 HbA1c 较高(平均 HbA1c:59mmol/mol;95%CI 59 至 60)。然而,在 T2DM/SMI 组中,孟加拉国人、印度人、巴基斯坦人和中国人的 HbA1c 水平高于英国白人参考值。被排除在按绩效付费计划之外的 T2DM/SMI 患者的 HbA1c 水平比未被排除在外的 T2DM/SMI 患者高+7mmol/mol(95%CI 2 至 11)。无论 SMI 状况如何,贫困程度增加和男性性别与 HbA1c 水平升高相关。
尽管有一个按绩效付费的计划来提高质量标准,但在被排除在计划之外的人群中,以及在性别、种族和地区贫困程度方面,患有 T2DM 和 SMI 的人的血糖管理不平等仍然存在。